Clinical Trials Logo

Clinical Trial Summary

For patients with sudden hearing loss, the initial treatment is not usually effective. We use Dexamethasone or Methylprednisolone to be an Intratympanic steroid administration as a salvage treatment. An randomized, double-blind, multi-center study is designed to find the difference between Dexamethasone or Methylprednisolone.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04129697
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact
Status Not yet recruiting
Phase N/A
Start date January 1, 2020
Completion date December 31, 2022